Food – Page 2 – Talk Bio

Actionable Insights Powered by AI

Merck & Co. predicts Keytruda will undergo IRA price cuts before patent cliff

7 months ago talkbio0Tagged Impact food supplement, IRA, Keytruda, Merck, Patent Cliff, Prices, Sales - occupational activity, U.S.

Merck, Keytruda, Prices, IRA, Sales – occupational activity, patent cliff, Impact food supplement, U.S., Keytruda

Legal Challenges Mount Against Trump’s NIH Funding Cuts

7 months ago talkbio0Tagged Economics, Impact food supplement, Indirect, NIH Mouse, research universities, Transitory

NIH funding cuts, indirect costs, research universities, lawsuits, temporary restraining order, economic impact

NIHs funding cut plan poses challenges for researchers despite court halt

7 months ago talkbio0Tagged Impact food supplement, Indirect, Legal, NIH Mouse, Research Projects, R-Series, Science

NIH funding cuts, indirect costs, research grants, legal challenges, scientific community impact

Sarepta Therapeutics and Arrowhead Pharmaceuticals Enter $825M Global Licensing and Collaboration Agreement for Multiple siRNA Programs

10 months ago talkbio0Tagged Arrowhead, Collaboration Agreement, gene therapy, Global Licensing, Hereditary Diseases, Infrequent, Interferes with, RNA, RNA, Small Interfering

Sarepta Therapeutics, Arrowhead Pharmaceuticals, siRNA programs, Global Licensing and Collaboration Agreement, Rare genetic diseases, Gene therapy, RNA interference

Sarepta Therapeutics and Arrowhead Pharmaceuticals Enter $10 Billion Collaboration for Rare Disease Treatments

10 months ago talkbio0Tagged Arrowhead, biotech, Collaboration, Drug Industry, Genetic Medicine, Infrequent, RNA Interference

Sarepta Therapeutics, Arrowhead Pharmaceuticals, RNAi, Rare Diseases, Genetic Medicine, Collaboration Agreement, Biotech, Pharmaceutical Industry

Healthcare Evolution 2025: AI, IRA, and GLP-1s Redefine the Industry

10 months ago talkbio0Tagged advancements, Aortic Valve Insufficiency, Biopharma, DNA Integration, Glucagon-Like Peptide 1, Health care facility, Healthcare technology, Impact food supplement, Ira (eukaryote), Pharmaceutical Industry Shifts, Telemedicine, trends qualifier, Value-Based Care

AI in Healthcare, IRA Impact on Biopharma, GLP-1 Medications, Healthcare Trends 2025, Value-Based Care, Telemedicine Integration, Pharmaceutical Industry Shifts, Healthcare Technology Advancements

Vaccine Stocks Plummet Globally Following RFK Jr.’s Nomination to Head HHS

10 months ago talkbio0Tagged Appointments, CHARGE Syndrome, Impact food supplement, Market, pharmaceutical companies, RFK Jr., stocks, Vaccines

RFK Jr., HHS appointment, vaccine stocks, pharmaceutical companies, stock market impact

Organon Expands Dermatology Portfolio with $1.2B Acquisition of Dermavant and VTAMA Cream

12 months ago talkbio0Tagged Acquisition (action), Dairy Cream, Dental Plaque, Dermatitis, Atopic, Dermatology field, Dermavant, Organon, Psoriasis, steroid-free skin cream, Vtama

Organon, Dermavant, VTAMA cream, dermatology, acquisition, steroid-free skin cream, plaque psoriasis, atopic dermatitis

Organon Expands Dermatology Portfolio with Acquisition of Dermavant for Up to $1.2 Billion

12 months ago talkbio0Tagged Acquisition (action), Dairy Cream, Dental Plaque, Dermatitis, Atopic, Dermatology field, Dermavant, Organon, Psoriasis, Roivant, tapinarof, Vtama

Organon, Dermavant, Roivant, dermatology, VTAMA cream, tapinarof, plaque psoriasis, atopic dermatitis, acquisition

Sanofi’s $1 Billion Bet on Muscular Dystrophy Drug Falters, Fulcrum Shares Plummet

12 months ago talkbio0Tagged Fulcrum, Impact food supplement, Market, muscular dystrophy drug, pharmaceutical failure, sanofi

Sanofi, Fulcrum, muscular dystrophy drug, pharmaceutical failure, stock market impact